JP2024515443A - 質量分析によるインスリン様増殖因子ｉバリアントの同定及び定量 - Google Patents

質量分析によるインスリン様増殖因子ｉバリアントの同定及び定量 Download PDF

Info

Publication number
JP2024515443A
JP2024515443A JP2023556942A JP2023556942A JP2024515443A JP 2024515443 A JP2024515443 A JP 2024515443A JP 2023556942 A JP2023556942 A JP 2023556942A JP 2023556942 A JP2023556942 A JP 2023556942A JP 2024515443 A JP2024515443 A JP 2024515443A
Authority
JP
Japan
Prior art keywords
igf
variants
mass
sample
ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515443A5 (enExample
Inventor
モトリキン，イエフゲン
クラーク，ナイジェル
マクファール，マイケル，ジェイ．
ウー，ゼングル
Original Assignee
クエスト ダイアグノスティックス インヴェストメンツ エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クエスト ダイアグノスティックス インヴェストメンツ エルエルシー filed Critical クエスト ダイアグノスティックス インヴェストメンツ エルエルシー
Publication of JP2024515443A publication Critical patent/JP2024515443A/ja
Publication of JP2024515443A5 publication Critical patent/JP2024515443A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2023556942A 2021-03-19 2022-03-18 質量分析によるインスリン様増殖因子ｉバリアントの同定及び定量 Pending JP2024515443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163163502P 2021-03-19 2021-03-19
US63/163,502 2021-03-19
PCT/US2022/020906 WO2022198020A1 (en) 2021-03-19 2022-03-18 Identification and quantitation of insulin-like growth factor-i variants by mass spectrometry

Publications (2)

Publication Number Publication Date
JP2024515443A true JP2024515443A (ja) 2024-04-10
JP2024515443A5 JP2024515443A5 (enExample) 2025-03-12

Family

ID=83284520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556942A Pending JP2024515443A (ja) 2021-03-19 2022-03-18 質量分析によるインスリン様増殖因子ｉバリアントの同定及び定量

Country Status (7)

Country Link
US (2) US12222354B2 (enExample)
EP (1) EP4308923A4 (enExample)
JP (1) JP2024515443A (enExample)
KR (1) KR20230169172A (enExample)
CN (1) CN117178188A (enExample)
CA (1) CA3212218A1 (enExample)
WO (1) WO2022198020A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117589998B (zh) * 2023-10-09 2025-11-18 融智生物科技（青岛）有限公司 胰岛素样生长因子i变体的定量检测试剂盒
CN117589997B (zh) * 2023-10-09 2025-11-21 融智生物科技（青岛）有限公司 Igf-1变体的定量检测方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
JP2007532882A (ja) * 2004-04-07 2007-11-15 ジェネンテック・インコーポレーテッド 抗体結合体の質量分析
JP2017503862A (ja) * 2014-01-12 2017-02-02 アイジーエフ オンコロジー、 エルエルシー インスリン様成長因子−１および上皮増殖因子を含む融合タンパク質およびそのバリアントならびにその使用
CN109957000A (zh) * 2017-12-14 2019-07-02 南开大学 一种促进细胞增殖的多肽衍生物及其制备方法及应用
US20210041462A1 (en) * 2009-11-05 2021-02-11 Quest Diagnostics Investments Incorporated Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064044A9 (en) 1995-05-23 2008-03-13 Nelson Randall W Analysis of insulin-like growth factors from biological fluids by the use of affinity-based mass spectrometric methods
EP1791551B1 (en) 2004-08-30 2020-02-26 Ipsen Biopharmaceuticals, Inc. Method and device for diagnosing and treating insulin-like growth factor deficiency disorders
EP1674113A1 (en) 2004-12-22 2006-06-28 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol)
ES2453108T3 (es) 2007-08-06 2014-04-04 Orion Genomics, Llc Nuevos polimorfismos de un único nucleótido y combinaciones de polimorfismos nuevos y conocidos para determinar la expresión específica de alelo del gen IGF2
EP2396429B1 (en) 2009-02-11 2015-05-27 Orion Genomics, LLC Combinations of polymorphisms for determining allele-specific expression of igf2

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
JP2007532882A (ja) * 2004-04-07 2007-11-15 ジェネンテック・インコーポレーテッド 抗体結合体の質量分析
US20210041462A1 (en) * 2009-11-05 2021-02-11 Quest Diagnostics Investments Incorporated Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry
JP2017503862A (ja) * 2014-01-12 2017-02-02 アイジーエフ オンコロジー、 エルエルシー インスリン様成長因子−１および上皮増殖因子を含む融合タンパク質およびそのバリアントならびにその使用
CN109957000A (zh) * 2017-12-14 2019-07-02 南开大学 一种促进细胞增殖的多肽衍生物及其制备方法及应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOTORYKIN ET AL.: "MON-487 Simultaneous Monitoring of 13 IGF-1 Variants in a Clinical Mass Spectrometry Assay", JOURNAL OF THE ENDOCRINE SOCIETY, vol. Vol.3/Issue Supplement_1, MON-487, JPN6025050175, 2019, pages 1 - 2, ISSN: 0005749318 *

Also Published As

Publication number Publication date
EP4308923A4 (en) 2025-01-08
EP4308923A1 (en) 2024-01-24
BR112023018869A2 (pt) 2023-12-05
KR20230169172A (ko) 2023-12-15
CN117178188A (zh) 2023-12-05
WO2022198020A1 (en) 2022-09-22
US20220299524A1 (en) 2022-09-22
US12222354B2 (en) 2025-02-11
CA3212218A1 (en) 2022-09-22
US20250155448A1 (en) 2025-05-15

Similar Documents

Publication Publication Date Title
US12493049B2 (en) Quantitation of insulin-like growth factor-I and insulin-like growth factor-II with high-resolution mass spectrometry
US12372539B2 (en) Quantitation of insulin by high resolution/high accuracy mass spectrometry using the 6+ multiply charged insulin ion
CA3000178C (en) Amyloid beta detection by mass spectrometry
US20250155448A1 (en) Identification and quantitation of insulin-like growth factor-i variants by mass spectrometry
US20250224404A1 (en) Detection of insulin-like growth factor-2 variants by mass spectrometry
BR112023018869B1 (pt) Método para detectar variantes do fator de crescimento tipo insulina-i em uma amostra por espectrometria de massa

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250304

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20250823

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260304